 |
|
|
| |
STaR Study: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF
Maintains Non-Inferiority to Efavirenz/Emtricitabine/Tenofovir DF in ART-Naïve Adults Week 96 Results
|
| |
| |
Reported by Jules Levin
14th European AIDS Conference
16-19 October, 2013
Brussels, Belgium
C Cohen1, D Wohl2, J Arribas3, K Henry4, J van Lunzen5, M Bloch6, W Towner7, E Wilkins8, R Ebrahimi9, D Porter9, K Patel9, S De-Oertel9, T Fralich9, B Guyer9
1Community Research Initiative of New England, Boston, Massachusetts USA; 2University of North Carolina at Chapel Hill, Chapel Hill, North Carolina USA;
3Hospital La Paz, Madrid, Spain; 4HIV Program Hennepin County Medical Center, Minneapolis, Minnesota, USA; 5University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6Holdsworth House Medical Practice, Darlinghurst, NSW Australia; 7Department of Infectious Disease Kaiser Los Angeles Medical Center, Los Angeles, California, USA; 8North Manchester General Hospital, Manchester, United Kingdom; 9Gilead Sciences, Foster City, California, USA
|
| |
|
|
|
|
|
